Format

Send to

Choose Destination
Nucleic Acids Res. 2018 Sep 28;46(17):8689-8699. doi: 10.1093/nar/gky706.

Chemical genetic inhibition of DEAD-box proteins using covalent complementarity.

Author information

1
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
2
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.
3
Department of Chemistry, University of California, Berkeley, CA 94720, USA.

Abstract

DEAD-box proteins are an essential class of enzymes involved in all stages of RNA metabolism. The study of DEAD-box proteins is challenging in a native setting since they are structurally similar, often essential and display dosage sensitivity. Pharmacological inhibition would be an ideal tool to probe the function of these enzymes. In this work, we describe a chemical genetic strategy for the specific inactivation of individual DEAD-box proteins with small molecule inhibitors using covalent complementarity. We identify a residue of low conservation within the P-loop of the nucleotide-binding site of DEAD-box proteins and show that it can be mutated to cysteine without a substantial loss of enzyme function to generate electrophile-sensitive mutants. We then present a series of small molecules that rapidly and specifically bind and inhibit electrophile-sensitive DEAD-box proteins with high selectivity over the wild-type enzyme. Thus, this approach can be used to systematically generate small molecule-sensitive alleles of DEAD-box proteins, allowing for pharmacological inhibition and functional characterization of members of this enzyme family.

PMID:
30102385
PMCID:
PMC6158709
DOI:
10.1093/nar/gky706
[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances, Grant support

Publication type

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center